Business Description
WntResearch AB
ISIN : SE0022239901
Compare
Compare
Traded in other countries / regions
WNT.SwedenK6Q.Germany IPO Date
2010-12-17Description
WntResearch AB is a cancer research company. The company develops anti-metastatic therapies based on the mechanisms underlying the metastatic process.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.87 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 37.5 | |||||
| 3-Year EPS without NRI Growth Rate | 37.1 | |||||
| 3-Year FCF Growth Rate | 39.7 | |||||
| 3-Year Book Growth Rate | -44.5 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.96 | |||||
| 9-Day RSI | 48.26 | |||||
| 14-Day RSI | 49.62 | |||||
| 6-1 Month Momentum % | 22.93 | |||||
| 12-1 Month Momentum % | -53.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.05 | |||||
| Quick Ratio | 7.05 | |||||
| Cash Ratio | 6.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -84 | |||||
| Shareholder Yield % | -27.61 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -107.52 | |||||
| ROA % | -92.39 | |||||
| ROIC % | -583.08 | |||||
| ROCE % | -110.45 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.2 | |||||
| Price-to-Tangible-Book | 2.35 | |||||
| EV-to-EBIT | -1.46 | |||||
| EV-to-Forward-EBIT | -1.48 | |||||
| EV-to-EBITDA | -1.47 | |||||
| EV-to-FCF | -1.33 | |||||
| Price-to-Net-Current-Asset-Value | 2.35 | |||||
| Price-to-Net-Cash | 2.68 | |||||
| Earnings Yield (Greenblatt) % | -68.32 | |||||
| FCF Yield % | -40.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
WntResearch AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -8.147 | ||
| Beta | 0.45 | ||
| Volatility % | 111.54 | ||
| 14-Day RSI | 49.62 | ||
| 14-Day ATR (kr) | 1.281924 | ||
| 20-Day SMA (kr) | 10.7395 | ||
| 12-1 Month Momentum % | -53.35 | ||
| 52-Week Range (kr) | 5.28 - 37.902438 | ||
| Shares Outstanding (Mil) | 8.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
WntResearch AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
WntResearch AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
WntResearch AB Frequently Asked Questions
What is WntResearch AB(XSAT:WNT)'s stock price today?
The current price of XSAT:WNT is kr10.80. The 52 week high of XSAT:WNT is kr37.90 and 52 week low is kr5.28.
When is next earnings date of WntResearch AB(XSAT:WNT)?
The next earnings date of WntResearch AB(XSAT:WNT) is 2024-08-22.
Does WntResearch AB(XSAT:WNT) pay dividends? If so, how much?
WntResearch AB(XSAT:WNT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers